|
G |
Arrb2 |
arrestin, beta 2 |
multiple interactions |
ISO |
S-nitrosocysteine inhibits the reaction [Isoproterenol affects the localization of ARRB2 protein] |
CTD |
PMID:17482545 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
S-nitrosocysteine inhibits the reaction [SIRT1 protein results in decreased cleavage of CASP3 protein] |
CTD |
PMID:24451382 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
increases nitrosation |
ISO |
S-nitrosocysteine results in increased nitrosation of GRK2 protein |
CTD |
PMID:17482545 |
|
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
EXP |
[S-nitrosocysteine results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein; Dithiothreitol inhibits the reaction [[S-nitrosocysteine results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein] |
CTD |
PMID:16386761 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
S-nitrosocysteine inhibits the reaction [SIRT1 protein results in decreased acetylation of TP53 protein]; S-nitrosocysteine inhibits the reaction [SIRT1 protein results in decreased cleavage of CASP3 protein] |
CTD |
PMID:24451382 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
S-nitrosocysteine inhibits the reaction [SIRT1 protein results in decreased acetylation of TP53 protein] |
CTD |
PMID:24451382 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
ISO |
AIFM1 protein inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased reduction of Glutathione]; AIFM1 protein promotes the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased reduction of Adenine Nucleotides] |
CTD |
PMID:15316071 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]]; Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]] |
CTD |
PMID:21138475 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of AQP3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases phosphorylation multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein] |
CTD |
PMID:21138475 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein] |
CTD |
PMID:21138475 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein] S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 mRNA; S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein |
CTD |
PMID:17135264 PMID:21138475 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions increases secretion |
EXP |
Carbon Dioxide inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased secretion of CALCA protein] |
CTD |
PMID:18052948 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased activity of and results in increased cleavage of CASP1 protein |
CTD |
PMID:10903723 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases activity increases activity |
ISO EXP |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of CASP3 protein] Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased activity of CASP3 protein] S-Nitroso-N-Acetylpenicillamine results in decreased activity of CASP3 protein |
CTD |
PMID:10811113 PMID:12006578 PMID:12220328 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased phosphorylation of CREB1 protein]; S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Quercetin results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:17135264 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of CSRP3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Drgx |
dorsal root ganglia homeobox |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of DRGX mRNA |
CTD |
PMID:12102619 |
|
NCBI chr16:7,854,849...7,884,404
Ensembl chr16:7,854,849...7,900,600
|
|
G |
Edn1 |
endothelin 1 |
increases secretion |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased secretion of EDN1 protein |
CTD |
PMID:15640287 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eln |
elastin |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of ELN mRNA |
CTD |
PMID:12102619 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Exoc6 |
exocyst complex component 6 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of SEC15 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:235,314,612...235,457,824
Ensembl chr 1:235,300,369...235,457,015
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] |
CTD |
PMID:10811113 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR2B mRNA |
CTD |
PMID:12102619 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] |
CTD |
PMID:16351512 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Ghrh |
growth hormone releasing hormone |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of GHRH mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
multiple interactions decreases expression |
EXP |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]; Uric Acid inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions decreases expression |
EXP |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]; Uric Acid inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of GOT1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein]]; GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; GPX1 protein affects the susceptibility to [Diquat co-treated with S-Nitroso-N-Acetylpenicillamine]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased expression of GPX1 protein] |
CTD |
PMID:11672444 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
multiple interactions |
EXP |
[S-Nitroso-N-Acetylpenicillamine co-treated with 2-tert-butylhydroquinone] results in increased expression of GSTA2 |
CTD |
PMID:15357004 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of HCK mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased expression of HMOX1 protein |
CTD |
PMID:16439612 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Streptozocin results in increased expression of IFNG protein] |
CTD |
PMID:15892581 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Itpka |
inositol-trisphosphate 3-kinase A |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of ITPKA mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases expression decreases phosphorylation increases phosphorylation multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK1 protein S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:15640287 PMID:19252090 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases expression multiple interactions increases phosphorylation decreases phosphorylation |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:15640287 PMID:19252090 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mme |
membrane metallo-endopeptidase |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MME mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mtf1 |
metal-regulatory transcription factor 1 |
affects localization |
ISO |
S-Nitroso-N-Acetylpenicillamine affects the localization of MTF1 protein |
CTD |
PMID:16423564 |
|
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of NFKB1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases activity decreases expression |
ISO EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased activity of NOS2 protein S-Nitroso-N-Acetylpenicillamine results in decreased expression of NOS2 promoter |
CTD |
PMID:11076874 PMID:15565661 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:11799084 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of NPR3 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
multiple interactions |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein] |
CTD |
PMID:18652891 PMID:21235400 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of PAM mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]] |
CTD |
PMID:10811113 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein] |
CTD |
PMID:18652891 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcg |
protein kinase C, gamma |
multiple interactions |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein] |
CTD |
PMID:18652891 PMID:21235400 |
|
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions increases activity |
EXP |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] S-Nitroso-N-Acetylpenicillamine results in increased activity of PRKG1 protein |
CTD |
PMID:11799084 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
increases activity |
EXP |
SNAP increases activity of Ptpn1 protein in aortic smooth muscle cells |
RGD |
PMID:10484424 |
RGD:401965470 |
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Rack1 |
receptor for activated C kinase 1 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of RACK1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein] |
CTD |
PMID:21235400 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rgs17 |
regulator of G-protein signaling 17 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein] |
CTD |
PMID:18652891 |
|
NCBI chr 1:42,222,248...42,324,625
Ensembl chr 1:42,227,070...42,324,609
|
|
G |
Rplp0 |
ribosomal protein lateral stalk subunit P0 |
decreases expression |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of RPLP0 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
|
|
G |
Sftpa1 |
surfactant protein A1 |
decreases expression multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr16:17,008,180...17,011,686
Ensembl chr16:17,008,180...17,011,685
|
|
G |
Sftpb |
surfactant protein B |
multiple interactions decreases expression |
EXP |
bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sftpc |
surfactant protein C |
multiple interactions decreases expression |
EXP |
bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions affects response to substance |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein] SOD1 protein affects the susceptibility to S-Nitroso-N-Acetylpenicillamine |
CTD |
PMID:10698074 PMID:11672444 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO EXP |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein] [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA |
CTD |
PMID:11672444 PMID:14996425 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of TRP53 mRNA S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] |
CTD |
PMID:7673702 PMID:16351512 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein] |
CTD |
PMID:20177073 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
increases phosphorylation |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of VASP protein |
CTD |
PMID:11799084 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression increases secretion |
EXP |
S-Nitroso-N-Acetylpenicillamine results in increased expression of VEGFA mRNA S-Nitroso-N-Acetylpenicillamine results in increased secretion of VEGFA protein |
CTD |
PMID:10613739 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects transport |
EXP |
ABCC2 affects the transport of S-Nitrosoglutathione |
CTD |
PMID:20683964 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
increases reduction multiple interactions |
ISO |
ADH5 protein results in increased reduction of S-Nitrosoglutathione decanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; dodecanedioic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; Glutathione inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; lauric acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; octanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; pelargonic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; S-methyl glutathione inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; S-Nitrosoglutathione promotes the reaction [ADH5 protein results in increased oxidation of Ethanol]; S-Nitrosoglutathione promotes the reaction [ADH5 protein results in increased oxidation of Formaldehyde]; S-Nitrosoglutathione promotes the reaction [ADH5 protein results in increased oxidation of Octanols]; sebacic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione]; undecanoic acid inhibits the reaction [ADH5 protein results in increased reduction of S-Nitrosoglutathione] [SPL-334 results in decreased activity of ADH5 protein] which results in decreased metabolism of S-Nitrosoglutathione |
CTD |
PMID:19038239 PMID:19428350 PMID:26209236 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Atm |
ATM serine/threonine kinase |
increases response to substance |
ISO |
ATM results in increased susceptibility to S-Nitrosoglutathione |
CTD |
PMID:8958160 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of BAX protein |
CTD |
PMID:10828028 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased expression of BCL2 protein |
CTD |
PMID:10828028 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
S-Nitrosoglutathione results in decreased expression of BNIP3 mRNA |
CTD |
PMID:11592958 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein; [tempol co-treated with UCF 101 co-treated with acetovanillone] inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein] Cyclosporine inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein] |
CTD |
PMID:10205001 PMID:10828028 PMID:20153346 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
S-Nitrosoglutathione results in increased activity of CASP8 protein |
CTD |
PMID:20153346 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cbr1 |
carbonyl reductase 1 |
multiple interactions increases reduction |
ISO |
[S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1,4-naphthoquinone]; [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 2,3-hexanedione]; [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 4-benzoylpyridine]; [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin]; [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3]; [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1,2-naphthoquinone]; [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 9,10-phenanthrenequinone]; [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of Isatin]; Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]]; S-Nitrosoglutathione binds to and results in decreased activity of CBR1 protein; S-Nitrosoglutathione binds to and results in increased activity of CBR1 protein; S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione] |
CTD |
PMID:21256830 PMID:23295225 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases secretion |
ISO |
S-Nitrosoglutathione results in decreased secretion of CCL5 protein |
CTD |
PMID:13678430 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
multiple interactions |
ISO |
CCT7 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased abundance of Cyclic GMP] |
CTD |
PMID:24213632 |
|
NCBI chr 4:117,989,232...118,006,478
Ensembl chr 4:117,989,232...118,006,580
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
ISO |
S-Nitrosoglutathione results in decreased expression of CD86 protein |
CTD |
PMID:13678430 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions increases expression decreases expression decreases activity |
ISO |
acivicin inhibits the reaction [S-Nitrosoglutathione results in increased expression of and results in increased stability of CFTR protein]; acivicin inhibits the reaction [S-Nitrosoglutathione results in increased expression of CFTR mRNA]; DDT inhibits the reaction [S-Nitrosoglutathione results in increased expression of and results in increased stability of CFTR protein]; S-Nitrosoglutathione results in increased expression of and results in increased stability of CFTR protein S-Nitrosoglutathione results in decreased expression of CFTR mRNA S-Nitrosoglutathione results in decreased activity of CFTR protein |
CTD |
PMID:14766015 PMID:15657297 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases secretion |
ISO |
S-Nitrosoglutathione results in decreased secretion of CXCL10 protein |
CTD |
PMID:13678430 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] |
CTD |
PMID:10811113 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
multiple interactions |
ISO |
GUCY1A1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased abundance of Cyclic GMP] |
CTD |
PMID:24213632 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression |
ISO |
S-Nitrosoglutathione results in increased expression of HIF1A mRNA |
CTD |
PMID:11514583 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
[linsidomine co-treated with S-Nitrosoglutathione] results in increased expression of HMOX1 mRNA; Nitroprusside promotes the reaction [S-Nitrosoglutathione results in increased expression of HMOX1 mRNA]; S-Nitrosoglutathione promotes the reaction [Nitroprusside results in increased expression of HMOX1 mRNA] |
CTD |
PMID:8764571 PMID:10423162 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
multiple interactions affects localization |
ISO |
[tempol co-treated with UCF 101 co-treated with acetovanillone] inhibits the reaction [S-Nitrosoglutathione affects the localization of HTRA2 protein] |
CTD |
PMID:20153346 |
|
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
|
|
G |
Ifng |
interferon gamma |
increases secretion |
ISO |
S-Nitrosoglutathione results in increased secretion of IFNG protein |
CTD |
PMID:13678430 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
decreases secretion |
ISO |
S-Nitrosoglutathione results in decreased secretion of IL10 protein |
CTD |
PMID:13678430 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
decreases expression |
ISO |
S-Nitrosoglutathione results in decreased expression of IL12B protein |
CTD |
PMID:13678430 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il5 |
interleukin 5 |
decreases secretion |
ISO |
S-Nitrosoglutathione results in decreased secretion of IL5 protein |
CTD |
PMID:13678430 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
affects metabolic processing multiple interactions |
EXP |
S-Nitrosoglutathione affects the metabolism of MGST1 protein [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein; Dithiothreitol inhibits the reaction [[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein] |
CTD |
PMID:16386761 PMID:16899233 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
[NOS2 protein results in increased chemical synthesis of S-Nitrosoglutathione] which results in decreased susceptibility to Carmustine |
CTD |
PMID:15110396 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
increases nitrosation |
EXP |
S-Nitrosoglutathione results in increased nitrosation of P4HB protein |
CTD |
PMID:28823167 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
[S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein binds to TP53 promoter]; [S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 mRNA]; [S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 protein]; S-Nitrosoglutathione inhibits the reaction [PRKN protein binds to TP53 promoter]; S-Nitrosoglutathione inhibits the reaction [PRKN protein results in decreased expression of TP53 mRNA]; S-Nitrosoglutathione inhibits the reaction [PRKN protein results in decreased expression of TP53 protein]; S-Nitrosoglutathione results in increased nitrosation of and affects the localization of PRKN protein |
CTD |
PMID:23985028 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
multiple interactions |
EXP |
S-Nitrosoglutathione results in increased nitrosation of and results in increased activity of RASD1 protein |
CTD |
PMID:16908409 |
|
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
S-Nitrosoglutathione promotes the reaction [Adenosine Triphosphate results in increased metabolism of RELA protein] |
CTD |
PMID:21464294 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sp1 |
Sp1 transcription factor |
increases activity |
ISO |
S-Nitrosoglutathione results in increased activity of SP1 protein |
CTD |
PMID:14766015 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sp3 |
Sp3 transcription factor |
decreases activity increases activity |
ISO |
S-Nitrosoglutathione results in decreased activity of SP3 protein S-Nitrosoglutathione results in increased activity of SP3 protein |
CTD |
PMID:14766015 |
|
NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion |
ISO |
S-Nitrosoglutathione results in increased secretion of TNF protein |
CTD |
PMID:13678430 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP ISO |
[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein [S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein binds to TP53 promoter]; [S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 mRNA]; [S-Nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 protein]; S-Nitrosoglutathione inhibits the reaction [PRKN protein binds to TP53 promoter]; S-Nitrosoglutathione inhibits the reaction [PRKN protein results in decreased expression of TP53 mRNA]; S-Nitrosoglutathione inhibits the reaction [PRKN protein results in decreased expression of TP53 protein] |
CTD |
PMID:8982730 PMID:23985028 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|